Nuo Therapeutics, Inc. announced that it has engaged Winter Harbor LLC to assist the company in its financial restructuring process. In connection with the engagement, Mr. Shaun Martin, a principal at Winter Harbor, has been appointed Chief Restructuring Officer of Nuo effective December 15, 2015, and will report directly to its Board of Directors. Mr. Martin is a co-founder of Winter Harbor LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | 0.00% | +0.01% | +36.36% |
05-20 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
05-15 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+36.36% | 33.83M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics Announces Appointment of Shaun Martin as Chief Restructuring Officer Effective December 15, 2015